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We have isolated two overlapping cDNA clones that provide the complete nucleotide sequence coding for 
the NC-l domain and 3’-untranslated region of the cl, chain of human type IV collagen as well as a sequence 
encoding 232 residues of the collagenous domain. An extensive homology was observed between the se- 
quences of the NC-l domain of the q(IV) and %(IV) chains, but considerably less between the sequences 
encoding collagenous and 3’-untranslated regions. There were four interruptions in the collagenous equence 
studied whereas the comparable region of the aI chain had only two. A potential oligosaccharide attach- 
ment site was found in a 6-residue long interruption of the collagenous domain but none in the NC-l 
domain. 
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I. INTRODUCTION 
Type IV collagen is the major structural compo- 
nent of basement membranes that is found only in 
these structures [l]. This collagen type is composed 
of two kinds of polypeptide chains, cyl (IV) and LYZ 
(IV), that form a triple helic molecule. Type IV 
collagen differs from the major fibrillar collagens 
of type I, II and III, in that the collagenous Gly-X- 
Y repeat sequence is frequentyly interrupted, has a 
globular domain (NC-l) only at the C-terminus 
that is not removed extracellularly and forms a 
network-like structure instead of cross-striated 
fibrils [ 1,2]. The differences between type IV and 
fibrillar collagens are reflected at the gene level: 
the exons coding for the Gly-X-Y repeats of the al 
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(IV) and LYZ (IV) chains do not follow the 54 bp rule 
found in the genes of fibrillar collagens [3-51. 
Thus, type IV collagen resembles more type VI, 
VII, VIII, IX and X collagens which do not form 
fibrils [6-lo]. 
The amino acid sequence of the NC-l domain of 
the human LYE (IV) chain has been determined [I l] 
as well as 907 residues from the C-terminal end of 
the triple-helical region [12] and 216 residues from 
the amino-terminal end [13], or about 70% of this 
185 kDa chain. The amino acid sequence of the 
NC-l domain and about 520 residues of the helical 
region of the mouse al (IV) have also been re- 
ported [ 14-161. An amino acid sequence of 5 11 
residues from the collagenous domain of the 
mouse CQ (IV) chain [17,18] and the predicted 
amino acid sequence of the NC-l domain [19,20] 
were recently reported. 
Here, we report the isolation and characteriza- 
tion of cDNA clones coding for 232 residues of the 
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C-terminal end of the helical region of the (Ye (IV) 
chain in man, the complete NC-l domain and the 
3 ’ -nontranslating region. 
2. MATERIALS AND METHODS 
2.1. Isolation of cDNA clones 
A human cDNA library in hgtll (Clonetech, 
Palo Alto, CA) was screened with mouse a2 (IV) 
coding cDNA clones PE18 and PElOA [3,20]. 
PE18 [3] is 1.1 kb and codes for a region of the 
helical part of the mouse a2 (IV) chain whereas the 
1.85 kb PElOA codes for the NC-l domain and the 
untranslated region [20]. A mixture of the two 32P- 
labelled cDNA inserts was used as probe to hy- 
bridize duplicate nitrocellulose filters at low 
stringency at 42°C in 5 x Denhart’s, 5 xSSC, 
0.1% SDS, 50 pg/ml ssDNA [21]. The filters were 
washed with 0.2 x SSC, 0.1% SDS at 55°C. 
2.2. Other procedures 
The DNA sequence was determined by the use of 
Ml3 cloning [22] and the dideoxynucleotide se- 
quencing method of Sanger [23] using the ‘univer- 
sal primer’ as well as synthetic specific 
oligonucleotides for priming. Restriction en- 
donuclease mapping was made on the cDNA in- 
serts subcloned from Agtll into the pBR322 
plasmid EcoRI site and Southern analysis [24] was 
used to orientate the clones with respect to each 
other and known mouse cDNA sequences. 
Northern analysis of RNA was carried out as in 
]211* 
3. RESULTS AND DISCUSSION 
3.1. Identification of cDNA clones 
Two overlapping human cDNA clones with in- 
sert sizes of 1.2 kb (HD-3) and 2.0 kb (HD-4) were 
isolated from the placenta cDNA library using the 
mouse CYZ (IV) coding cDNA clones as probes. 
Analysis of the clones demonstrated that they 
cover 2220 bp (fig.l), or about one-third of the 
mRNA (7.3 kb, not shown). Comparison of the 
encoded amino acid sequence with that reported 
for mouse [17-201 demonstrated that the HD-3 
and HD-4 clones coded for the cry2 (IV) collagen 
chain. The sequence encodes 232 amino acids of 
the C-terminal end of the collagenous domain, the 
complete NC-l domain and the untranslated 
3’-region with a poly(A) tail (fig.2). 
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3.2. Sequence of the a2 (IV) collagenous domain 
The nucleotide sequence coding for the col- 
lagenous domain and the derived amino acid se- 
quence, aligned with that of the human cyi (IV) 
chain, is shown in fig.2. Out of 232 amino acid 
residues 105 or 45% are identical between the 
human LYE (IV) and human cyr (IV). However, the 
degree of homology was highly uneven between the 
residues of the Gly-X-Y repeats. Thus, 71 out of 75 
glycine residues in the cyr (IV) chain had a match 
in the LYZ (IV) chain, meaning that 95% of them 
were identical, whereas only 22% of the amino 
acids in the X-Y position of the Gly-X-Y repeats 
were identical (table 1). No cysteine residues were 
found in the collagenous equence characterized in 
this study. The human CQ (IV) sequence studied 
here contains four interruptions in the Gly-X-Y 
repeats (I-IV, fig.%) whereas the LY~ (IV) chain has 
only two in the same region. In two of the interrup- 
tions (II,IV, fig.2) the Gly-X-Y sequence was 
discontinued so that a glycine was replaced by an 
alanine. In both cases the codon for alanine was 
GCT. At comparable sites in the aligned human (~1 
(IV) chain sequence there was a complete Gly-X-Y 
sequence with glycine codons GGG and GGT (see 
II 11). 
In the third interruption of six residues (I, fig.2) 
two glycines had been substituted. This sequence is 
interesting since it contains an Asn-Ile-Ser se- 
quence that could form a site for an asparagine- 
linked oligosaccharide reported to be present in 
type IV collagen [25]. This interruption is out of 
frame with the w (IV) helical sequence because one 
amino acid has been deleted from the latter. This 
might result in the formation of one of the kinks 
in the type IV collagen molecule observed by 
rotary shadowing electron microscopy [ 1,2]. 
Nucleotide sequencing of the two cDNA clones 
studied here revealed one difference in the overlap- 
ping regions of the HD-3 and HD-4 clones in- 
dicating a polymorphic site in the coding region of 
the gene. This difference involved the codon for 
one of the amino acids in the 7-residue interruption 
(III, fig.2). As seen in the box in fig.2, the HD-4 
cDNA clone had a codon ATC for isoleucine 
(- 87) whereas the HD-3 cDNA clone had the 
codon GTC coding for valine at the same site. This 
polymorphic sequence was confirmed by’ restric- 
tion endonuclease digestion with FokI whose 
recognition sequence is 5 ’ . . . Ni3CATCC. . .3 ’ . 
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Fig.1. Map of two cDNA clones encoding human ~2 (IV) collagen. The position of the two cDNA clones (HD-3 and 
HD-4) with respect to the (~2 (IV) chain domains is illustrated at the top. The EcoRI sites in parentheses are contributed 
by linkers to the cDNA. 
The enzyme cleaved the HD-4 but not the HD-3 
cDNA clone (not shown). Interestingly, the mouse 
~YZ (IV) chain has a valine at this site [ 17,181 
whereas the human cyl (IV) has isoleucine ([ll]; see 
fig.2). 
Comparison of the sequence with that of mouse 
[17,18] showed that 80% of the nucleotides and 
84% of the amino acids were identical. None of the 
nucleotide changes results in an exchange of 
glycine in the Gly-X-Y repeats. 
3.3. C-terminal noncollagenous (NC-l) domain 
The nucleotide sequence of the cDNA clones 
revealed that the NC-I domain of the human a~2 
(IV) chain contains 227 amino acid residues (fig.2). 
This is the same as in mouse [20] but two residues 
less than in the LYE (IV) of man ([ll]. fig.2) and 
mouse [14] (see fig.3). The amino acid sequence 
did not contain any Asn-X-Ser or Asn-X-Thr se- 
quences indicating that the NC-1 domain does not 
contain any asparagine-linked carbohydrates. 
Comparison of the human CYZ (IV) chain amino 
acid sequence with that of the (~1 (IV) chain (fig.2) 
demonstrated an extensive homology between 
them as has recently been reported for mouse 
[19,20]. Out of the 227 amino acids in the (~2 (IV) 
chain NC-l domain 147 amino acids or 65% were 
identical with the cyl (IV) chain (table I). This 
means a homology of 65% which is considerably 
higher than what we observed between the se- 
quences of the two chains in the collagenous do- 
main (see above). In addition to the differences in 
the amino acid sequence, there are a few mis- 
matches between the chains where an amino acid is 
missing from one chain. Thus Ser (+92), Ala 
( + 94) and Glu ( + 200) in the a~1 (IV) chain do not 
have a match in the CYZ (IV) chain and Asn (+ 174) 
and Pro ( + 195) in the a2 (IV) chain do not have 
a match in the sequence of the CYI (IV) chain (see 
fig.2). 
Comparison of the human a2 (IV) sequence with 
that of mouse [19,20] demonstrated 77 differences 
in bases between the two species meaning that 89% 
are identical. Of those differences 66 involved the 
third base of the codon, and only one of them 
resulted in replacement of an amino acid. Out of 
the 227 amino acids residues of the NC-l domain, 
only 8 differ between man and mouse yielding a 
homology of 97%. In seven of the eight cases an 
uncharged amino acid is replaced by an uncharged 
one and in one case an aspartate is substituted by 
a glutamate residue. None of the differences in- 
volve cysteine indicating that the intrachain bonds 
are essential for the structure and function of the 
protein. 
The extensive homology of the amino acid se- 
quence between the NC-l domains of the a~ (IV) 
and CYZ (IV) chain is further signified by the com- 
parison of the sequences from both chains from 
man and mouse. The sequences were aligned for 
maximal homology (fig.3) and it can be seen that 
there is a conservation of all the cysteine residues 
and thus the three internal homologies (I-III) pre- 
sent in the two halves of the domain [l 1,141. There 
is a conservation of about 64% of the amino acids 
between the two chains from both species. 
3.3. Nucleotide sequence of the 3 ‘-untranslated 
region 
The 3 ‘-untranslated region of the human cy2 (IV) 
cDNAs contains a TGA stop codbn, 835 nucleo- 
tides and a poly(A) tail (fig.3). The base composi- 
tion in the human a2 (IV) chain was 24.8% A, 
23.3% T, 22.2% G and 29.6% C when it was 
31.3% A, 33.0% T, 16.6% G and 19.2% C in the 
human aI (IV) chain, respectively [12]. No ap- 
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-696 
-232 
-231 
I 
GGGGMCGAGGCCCACCTGGGAGCCCAGGACTTCAGGGGTTCCCAGGCATCACACCCCCTTCCMCATCTCTGGGGCACCTGGTGAC~GGG~GCCA~GATATTTGGCCTGAMGGT 
GERGPPGSPGLQGFPGIT GAPGDKGAPGIFGLKG 
-FM----PQ-QP_;L--SP -PX--R-PQ-QP--P- 
-576 TATCGGGGCCCACCAGGGCCACCAGGTTCTGCTGCTlCllGGGCCGGGGACTCCGGGCCC 
-192 YRGPPGPPGSA~~GSSGGTGNPGAPGTPGTTGWAGGSGP 
-192 L P - - M----LPGID _"__-K__-_W--A--"P-PK--P-F 
-456 
-152 
-152 
-336 
-112 
-112 
CAGGGCAGGCCTGGTGTGTTTGGTCTCCCAGGAGARRAAGGGCCCAGGGGTGMCMGGCTTCATGGGGMCACTGGACCCACCGGGGCGGTGGGCGACAGAGGCCCCAA~ACCCMG 
QGRPGVFGLPGEKGPRGEQGFMGNTGPTGAVGDRGPKGPK 
--M--IG- S--IT-SK-DM-PP-VP-FQ- PK-LP-LQ-I- 
III 
GGAGACCCAGGATTCCCTGGTGCCCCGGGACTGTGGGAGCCCCCGGGATTGCAGG~T~CCCAG*GATT~CATC~CCAGGGACAGTGGGTCCCCAGGGGAGGCGAGGCCCCCCT 
GDPGFPGAPGTVGAPGIAGIP GTVGPQGRRGPP 
--Q-DC) -V--AK-L--PP-P- -EP-LP-PE--- 
IV 
-216 
-72 
-12 
-96 
-32 
-32 
+22 
+9 
+9 
GGGGCACCGGGGGAGATCGGG~~CCA~~~~~~~~C~~~~G~~~A~~~~~~~~~~~~~C~C~AG~~~~~TG~GCCCCMGGMGAGGTGGTGTGT~TGC~~TTCC~~~~T~~~~~~~ 
GAPGEIGPQGPPGEPGFRGAPGKAGPQGRGGVSIRGFRG 
-LK-LQ- LP--K-QQ- VT-LV-IP--P-IP-FDGA--QK- 
GATGMGGACCCATAGGCCACCAGGGGCCGATTGGCCMGMGGTGCACCAGGCCGTCCAGGGAGCCCGGGCCTGCCGGGTATGCCAGGCCGC AGETCAGCAT G TACCTCCTG 
DE G P IGHQGPIGQEGAPGRPGSPGLPGHPGR SVSIGYLL 
EM--A-P T--R- FP -P --P D - L -- SM-P - - TP.- - DH-F-V 
GTGMGCACAGCCAGACGGACCAGGAGCCCATGTGCCCGGTGGGCATGMCAMCTCT~AGTGGATACA~CTGCTGTACTTCGAGGGCCA~GMGGCGCAC~CCAGGACCTGGGG 
VKHSQTDQEPMCPVGMNKLWSGYSLLYFEGQEKAHNQDLG 
TR----IDD-Q- _s_T~~-~H___--_VQ-N-R-_G_-_- 
+142 
+4e 
+49 
CTGGCGGGCTCCTGCCTGGCGCGGTTCAGCACCATGCCCTTCCTGTACTGCAACCCTGGTGATGTCTGCTACTATGCCAGCCGGMCGACMGTCCTACTGGCTCTCTACCACTGCGCCG 
LAGSCLARFSTMPFLYCNPGDVCYYASRNDKSYWLSTTAP 
+262 
+88 
+a9 
+376 
+126 
+129 
+496 
Cl66 
+169 
+613 
+205 
+207 
CTGCCCATG ATG CCCGTGGCCGAGGACGAGATCMGCCCTACATCAGCCGCTGTTCTGTGTGTGAGGCCCCGGCCATCGCCATCGC~TCCACAGTCAGGATGTCTCCATCCCA 
L P I4 M PVAEDEIKPYISRCSVCEAPAIAIAVHSQDVSIP 
M - - s - A-ITGEN_R_F____A_-__--~V~----_TIQ__ 
CACTGCCCAGCTGGGTGGCGGAGTTTGTGGATCGGATATTCCTTCCTCATGCACACGGCGGCGGGAGACGMGGCGGTGGCCMTCACTGGTGTCACCGGGCAGCTGTCTAGAGGACTTC 
HCPAGWRSLWIGYSFLMHTAAGDEGGGQSLVSPGSCLEDF p--s-_s-_-_-__ _ v - _ _S__A-_S--A-A---_-__~_ 
CGCGCCACACCATTCATCGMTGCMTGGAGGCCGCG~ACCTGCCACTACTACGCC~CMGTACAGCTTCTGGCTGACCACCATTCCCGAGCAGAGC TTCCAGG CT GCCCTCC 
RATPFIECNGGRGTCHYYANKYSFWLTTIPEQS FQGSPS 
_S A_-_-- H___-_N-___A_-__-A-- - R-EMFKK-T 
GCCGACACGCTCMGGCCGGCCTCATCCGCACACACATCAGCCGCTGCCAGGTGTGCATGMGAACCTGTGAGCCGGCGCGTGCCAGGMGGGCCATTTTGGTGCTTATTCTT~CTTAT 
ADTLKAGLIRTHISRCQVCMKNL' pS__-_-EL_-_v_____--RRT 
733 TACCTCAGGTGCCAACCAAAAATTGGTTTTATTTTTTTCTTAAAAAA AAAAR~GTCTACCAAAGGAATTTTGCATCCAGCAGCAGCACTTAGACCTGCCAGCCACTGTCACCGAGCGGG 
853 TGCMGCACTCGGGGTCCCTGGAGGCMGCCCTGCCCACAG~GCCAGGAGCAGCCCTGGCCCCCATCAGCCCTGCTACGACGCACCGCCTGMGGCACAGCTMCCACTTCGCACACA 
973 CCCATGTMCCACTGCACTTTCCAATGCCACAGACMCTCACATTGTTCMCTCCTTCTCGGGGTGGGACAGACGAGACMCAGCACACAGGCAGCCAGCCGTGGCCAGAGGCTCGAGGG 
1093 GCTCAGGGGCTCAGGCACCCGTCCCCACACGAGGGCCCCGTGGGTGGCCTGGCCCTGCTTTCTACGCCAATGTTATGCCAGCTCCATGTTCTCCCRRRTTATTTT 
1213 AMGGCAAAACTGTGCTCTTTATTTTAAAAAACACTGATMTCACACTGCGGTAGGTCATTCTTTTGCCACATCCCTATAGACCACTGGGTTTGGCM~CTCAGGCAGMGTGGAGACC 
1333 TTTCTAGACATCATTGTCAGCCTTGCTACTTGAAGGTACACCCCATAGGGTCGGAGGTGCTGTCCCCACTGCCCCACCTTGTCCCTGAGATTTMCCCCTCCACTGCTGGGGGTGAGCTG 
1553 TACTCTTCTGACTGCCCCCTCCTGTGTAACGACTACMARTARRACTTGGTTCTGMTATTTTT~~ 
PQKIAIQ 
CCCCAGAAGATT- HD-4 
CCCCAGAAGATTGCCGTCC HD-3 
2 0 K I A" 0 
Fig.2. Nucleotide sequence and the deduced amino acid sequence for human CYZ (IV) chain coding cDNAs. The first 
row shows the nucleotide sequence of cDNA clones, the second row depicts the predicted amino acid sequence for the 
LYE (IV) and the third row indicates the amino acid sequence of the human LYI (IV) chain [11,12] where they differ from 
the LYZ (IV). Numbered boxes within the sequence surround interruptions in the collagenous Gly-X-Y repeats. The 
shaded part of box I illustrates a potential carbohydrate attachment site. Nucleotides (and amino acids) are numbered 
so that the last nucleotide of codon (or amino acid) for the Gly-X-Y domain is designated as ‘ - 1’ and the first codon 
and amino acid of the NC-l domain are designated as ‘ + 1’ (see [ll]). Filled arrowheads indicate the boundary of the 
collagenous and NC-l domains. The open arrowheads designate a segment in the HD-4 clone with a recognition site 
for FokI not present in HD-3 (see text). This segment from HD-4 is compared with the a segment from the same region 
of HD-3 clone in the separate box shown below. The single base substitution results in the replacement of isoleucine 
in HD-4 by valine in HD-3. The FokI recognition site is underlined. 
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Table 1 
Homology between amino acid sequence of human CYZ (IV) and CYI 
(IV) chains 
Collagenous domain= NC- 1 domain 
Gly- -X-Y- 
Identical residues (To) 95 22 65 
a Involves 232 amino acid residues from the C-terminal end of the 
domain. Gly refers to the first and -X-Y- to the second and third .‘; 
amino acid in the collagenous Gly-X-Y repeats 
parent homologies with cDNAs for pro-cur (I) and 
pro-cuz (I) chains from man and chick, pro-cut (II) 
from chick and man, and pro-cur (III) from chick 
were observed. 
3.4. Conclusion 
The two cDNA clones described here provide the 
first complete sequence coding for the NC-l do- 
main and 3 ‘-untranslated region of the human 
type IV collagen LYZ chain, as well as the sequence 
encoding 232 residues of the collagenous domain. 
A striking feature was the extensive homology be- 
tween the sequence of the NC-l domain of the LYI 
(IV) and LYE (IV) chains from both man and mouse 
[19,20] and considerably less homology between 
sequences coding for the collagenous domain or 
3 ‘-untranslated region. This high degree of conser- 
vation of sequences between two related proteins 
from different species indicates that the mainten- 
ance of structure of the NC-l domain is crucial for 
the function of the protein, be it chain assembly or 
intermolecular crosslinking. It also suggests that 
the two genes have evolved from the same ancestor 
gene (see [19,20]). Another striking finding was the 
presence of interruptions in the collagenous Gly-X- 
Y repeat sequences that did not have complete 
matches in the LYI (IV) chain. Such short discon- 
tinuities of the helix could explain the presence of 
kinks found in type IV collagen by rotary shadow- 
ing [l]. It was also interesting to note that only 
22% of the amino acids in the X-Y pbsition of the 
Gly-X-Y- repeats were conserved in both chains, 
whereas almost all the glycines, or 95%, were con- 
served. This indicates that there has been much 
higher tolerance for amino acid changes in the col- 
lagenous domain than in the NC-l domain, given 
that the triple helical structure was maintained by 
conserving glycine in every third position. One 
triplet sequence, Asp-Ile-Ser, a potential attach- 
ment site for oligosaccharides, was found in one of 
the interruptions. Since mannose has been found 
in type IV collagen and there are no Asn-X-Ser or 
Asn-X-Thr sequences in the NC-l domains or 
knowingly elsewhere in type IV collagen, this site 
could really be the attachment site for mannose. 
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